Go Symbol Lookup
Loading...

After-Hours Buzz: Gap, Pandora, Salesforce.com & More

Beverages

More

  • UPDATE 3-Kraft Foods profit beats Street, shares rise Thursday, 2 May 2013 | 6:53 PM ET

    May 02- Kraft Foods Group Inc posted quarterly earnings that far exceeded Wall Street estimates on Thursday, as increased spending on some of its biggest brands paid off, sending the company's shares higher.

  • **APPLE INC, $447.94, up 2 pct. William Blair& Co analyst Anil Doradla said the bond oversubscription showed investor confidence in Apple, adding that shareholders will get these benefits, and that capital allocation is driving the shares up. **AVEO PHARMACEUTICALS INC, $2.69, down 49 pct.

  • Derby's $1,000 Mint Julep  Thursday, 2 May 2013 | 2:00 PM ET

    CNBC's Brian Shactman is at the home of Saturday's Kentucky Derby, where Brown-Forman has cooked up a mint julep with a $1,000 price tag. Tim Laird, Brown-Forman's "Chief Entertaining Officer" makes one for Brian and explains what makes it so expensive.

  • **GENERAL MOTORS CO, $31.5, up 4 pct. **VISA INC, $170.8, up 3 pct. **FACEBOOK INC, $28.17, up 3 pct.

  • EU mergers and takeovers (May 2) Thursday, 2 May 2013 | 6:58 AM ET

    --Russian dairy producer OJSC Unimilk Co, which is controlled by French food group Danone Group, and French logistics company NDL International, which is controlled by French transport group Norbert Dentressangle, to form a logistics joint venture.

  • LONDON, May 2- JP Morgan and Greenhill. have been appointed to advise GlaxoSmithKline on the sale of its soft drinks brands Lucozade and Ribena, which analysts believe will fetch more than 1 billion pounds.

  • U.S. stocks extended their advance on Thursday, with the Nasdaq Composite up 1 percent, led by gains in shares of Apple and Gilead Sciences. **GILEAD SCIENCES INC, $52.88, up 5 pct.

  • **MERCK& CO INC, $45.95, down 2 pct. **TITAN PHARMACEUTICALS INC, $0.46, down 73 pct. **NEUTRAL TANDEM INC, $4.57, up 53 pct.

  • **MERCK& CO INC, $44.76, down 5 pct. **TITAN PHARMACEUTICALS INC, $0.34, down 80 pct. U.S. health regulators rejected an experimental drug to treat opioid addiction made by Titan Pharmaceuticals and asked for additional data showing it works, the company said.

  • **MERCK& CO INC, $44.76, down 5 pct. **TITAN PHARMACEUTICALS INC, $0.34, down 80 pct. **NEUTRAL TANDEM INC, $4.12, up 38 pct.

  • LONDON, May 1- Sugar futures were steady on Wednesday as the market digested reports of a huge delivery against expiry of the ICE May contract, while arabica coffee was little changed near multi-year lows weighed by a big off-year crop in Brazil. *Traders anticipated origins to be Brazil, Central America and even Mexico in a market awash with global supplies.

  • NAIROBI, April 30- The top price of Kenya's benchmark coffee grade AA dropped to $318 per 50- kg bag at auction from $433 per bag at last week's sale, the Nairobi Coffee Exchange said on Tuesday.

  • Nestle to open Cameroon's 1st coffee processing plant Wednesday, 1 May 2013 | 12:57 AM ET

    YAOUNDE, May 1- Nestle's Cameroon subsidiary said it would begin construction in August of the Central African nation's first coffee processing plant, in a move to supply what is expected to be a growing regional market.

  • April 30- Monster Beverage Corp has sued San Francisco's city attorney over an investigation the city launched last year into the safety and marketing of Monster energy drinks.

  • Dr Pepper's Secret Recipe  Tuesday, 30 Apr 2013 | 2:58 PM ET

    The secret recipe of Dr Pepper is inside a vault at the company's headquarters, reports CNBC's Jane Wells. Dr Pepper Snapple is doubling down on marketing in the current quarter.

  • NAIROBI, April 30- The top price of Kenya's benchmark coffee grade AA dropped to $318 per 50- kg bag at auction from $433 per bag at last week's sale, the Nairobi Coffee Exchange said on Tuesday.

  • Dr. Pepper Battles Soda Backlash  Tuesday, 30 Apr 2013 | 11:52 AM ET

    The beverage maker is working hard to develop new products to offset the trend among consumers to drink less of its drinks, reports CNBC's Jane Wells.

  • Staff reviewers for the U.S. Food and Drug Administration are expected to ask a panel of medical experts on May 2 if another clinical trial is required before it approves an experimental kidney cancer drug made by Aveo Oncology and Astellas Pharma Inc. **MGIC INVESTMENT CORP, Monday close $5.48, down 13 pct premarket.

  • BRIEF-Cott U.K. business to buy Calypso Soft Drinks Tuesday, 30 Apr 2013 | 8:56 AM ET

    *Announces U.K. reporting segment's planned acquisition of calypso soft drinks.

  • **MGIC INVESTMENT CORP, Monday close $5.48, down 13 pct premarket. **PFIZER INC, Monday close $30.43, down 3 pct premarket. **ZOETIS INC, Monday close $32.66.